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Abstract
Objective: Fertility in males with congenital adrenal hyperplasia (CAH) is reported from normal to
severely impaired. Therefore, we investigated fertility/fecundity, social/sexual situation, and pituitary–
gonadal function in CAH males.
Subjects and methods: The patient cohort comprised 30 males, aged 19–67 years, with 21-hydroxylase
deﬁciency. Their fertility was compared with age-matched national population data. For the evaluation
of social/sexual factors and hormone status, age-matched controls were recruited (nZ32). Subgroups
of different ages (!30 years and older) and CYP21A2 genotypes (null (severe salt-wasting (SW)),
I2splice (milder SW), and I172N (simple virilizing)) were also studied. Patients underwent testicular
ultrasound examination (nZ21) and semen analysis (nZ14).
Results: Fertility was impaired in CAH males compared with national data (0.9G1.3 vs 1.8G0.5
children/father, P!0.001). There were no major differences in social and sexual factors between
patients and controls apart from more fecundity problems, particularly in the I172N group. The
patients had lower testosterone/estradiol (E2) ratio and inhibin B, and higher FSH. The semen samples
were pathological in 43% (6/14) of patients and sperm concentration correlated with inhibin B and
FSH. Testicular adrenal rest tumors (TARTs) were found in 86% (18/21). Functional testicular volume
correlated positively with the testosterone/E2 ratio, sperm concentration, and inhibin B. Patients
with pathological semen had increased fat mass and indications of increased cardiometabolic risk.
Conclusions: Fertility/fecundity was impaired in CAH males. The frequent occurrence of TARTs
resulting in testicular insufﬁciencyappears to be the major cause, but other factors such as elevated fat
mass may contribute to a low semen quality.
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Introduction
Reported fertility in males with congenital adrenal
hyperplasia (CAH) has ranged from normal (1) to
severely impaired (2). The occurrence of testicular
adrenal rest tumors (TARTs) is considered to be the
main reason for fertility problems. Their typical location
in the rete testis is associated with the riskof obstruction
of the seminal ducts, with subsequent permanent
testicular damage. Increased adrenal androgens due to
not only undertreatment but also overtreatment with
glucocorticoids, leading to gonadotropin suppression,
may hamper fertility (3, 4).
The relative impact of different components involved
is not evident from previous studies. One reason may
be the different modes of evaluation used. Testicular
function has been studied by measuring inhibin B and
serum gonadotropin levels, along with semen analysis
and/or the number of biological children. TARTs
have been diagnosed using palpation, ultrasound, or
magnetic resonance imaging (1, 2, 4, 5, 6, 7, 8, 9, 10,
11, 12).
We have previously shown that reduced fertility in
females with CAH is mainly attributable to social and
sexual issues (13), but very little is known about these
issues in males with CAH.
Thus, the aim of this study was not only to evaluate
fertility, fecundity, and TARTs in adult CAH males, but
also to investigate the social and sexual factors of
importance for fertility. Moreover, younger and older
patients, as well as different CYP21A2 genotypes, were
compared to reveal the potential changes associated
with age or disease severity.
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Subjects
CAH males, R19 years of age, were mainly recruited
from the two participating university hospitals. The
diagnosis was conﬁrmed by mutation analyses of the
CYP21A2 gene (31 patients) or the HSD3B2 gene (one
patient).
The data were divided into subgroups according to
age as !30 years and older and according to the three
most prevalent CYP21A2 mutations as null, I2splice,
and I172N. In compound heterozygotes, the mildest
mutation deﬁnes the genotype group. Null is associ-
ated with the salt-wasting (SW) phenotype, I2splice is
most often associated with the SW phenotype but
some patients may escape SW, and I172N typically
leads to simple virilizing (SV) CAH. Matched controls
born on the same date as the patients were recruited
from the National Population Registry. The only
exclusion criterion was severe mental or psychiatric
disturbance with inability to consent to the study.
Age-matched national fertility data were also used
(children/father) (14).
This study was approved by the Ethics Committees of
the Karolinska Institute, Stockholm, and the University
of Gothenburg, Go ¨teborg, Sweden. All participants gave
their written informed consent.
Study protocol
Patients and controls were examined as outpatients
at Karolinska University Hospital (22 patients and
22 controls), Stockholm, or Sahlgrenska University
Hospital (ten patients and ten controls), Go ¨teborg,
Sweden. Serum and plasma samples were collected in
the morning after an overnight fast before morning
medication. All participants answered questionnaires
concerning social and sexual issues, fertility, and
fecundity. Fecundity problems were deﬁned as
attempting to become a father for O1 year. Patients
underwent testicular ultrasound imaging and were
also asked to deliver a semen sample. Published data
from this cohort on body composition measured
by dual-energy X-ray absorptiometry and cardio-
vascular risk factors (15) were used to evaluate
whether differences could be found in these para-
meters between patients with normal and patients
with pathological semen.
Testicular examination
The testicles were only examined at one of the
participating centers. This was done by manual
palpation and ultrasound. An orchidometer was used
to estimate the volume. The ultrasound examinations
were performed by one physician (S Granberg) using
a Voluson Expert 730 machine equipped with a
6–16 MHz real-time three-/four-dimensional linear
probe (GE Healthcare Austria GmbH & Co. OG, Zipf,
Austria). Total testicular, TART, and functional (total
testicularKTART) volumes were estimated using the
formula for a prolate ellipsoid (maximal length!
maximal width!maximal depth!0.523) (16).
Semen analysis
Seminal ﬂuid was collected after 1–4 days of
ejaculatory abstinence. The analyses included assess-
ment of semen volume, sperm concentration, total
sperm count, motile and immotile spermatozoa, and
morphology. Results were evaluated according to the
World Health Organization (WHO) standard (17).
Biochemical assays
Serum testosterone, sex hormone-binding globulin
(SHBG), and dried blood spot 17-hydroxyprogesterone
(17OHP, measured at 0800, 1400, 1900, 0100, and
0600 h), and 24-h urinary pregnanetriol were
measured as described previously (15). Bioactive
testosterone was calculated from total testosterone,
SHBG, and albumin (18). Serum FSH, LH, estradiol
(E2), and total prostate-speciﬁc antigen (PSA) and free
PSA were measured by ﬂuoroimmunoassay (Auto-
Delﬁa, PerkinElmer, Waltham, MA, USA). FSH and LH
had normal ranges of 1.0–10 U/l. Serum inhibin B
was measured by ELISA (Beckman Coulter, Toronto,
ON, Canada; normal range was 25–325 ng/l and
detection limit was 10 ng/l). Plasma ACTH was
measured on an advantage automatic immune
analyzer and plasma renin by immunoradiometric
assay (both from Nichols Institute Diagnostics, San
Clemente, CA, USA).
Statistical analysis
SigmaStat for Windows (Jandel Scientiﬁc, Erkarath,
Germany) was used for data analysis. Results are
presented as meanGS.D. if not otherwise stated. An
unpaired t-test was used to compare two groups when
values were normally distributed. Otherwise, the
Mann–Whitney rank sum test was used and in these
cases the median and range were reported. One-way
ANOVA was used when comparing three groups with
continuous variables and if normally distributed,
followed by the post-hoc Bonferroni t-test; otherwise,
the Kruskal–Wallis test was performed, followed by the
post-hoc Mann–Whitney rank sum test and Dunn’s
method. c
2 test or Fisher’s exact test was used in
frequency table calculations. All proportions were
calculated discounting missing values. Spearman’s
correlation coefﬁcient was used for correlation
analyses. Statistical signiﬁcance was set at P!0.05
and tendency at 0.05–0.10.
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Characteristics of the patients and controls
The characteristics of the patients have been described
earlier (15). In brief, 32 males with CAH, aged 19–67
years, were examined. Thirty-one had 21-hydroxylase
deﬁciency. Eighteen had been diagnosed with the SW
phenotype (genotype groups: null, nZ7; I2splice, nZ9;
I172N, nZ1; and C75R, nZ1). One patient had 3-beta-
hydroxysteroid dehydrogenase (3b-HSD) type II deﬁci-
ency (genotype: C75R). Twelve patients had been
diagnosed with the SV form (I172N, nZ8; I2splice,
nZ3; and P453S, nZ1). One SV patient had karyotype
46,XX (I2splice). Two patients had the non-classic (NC)
phenotype with normal baseline ACTH levels (mildest
mutation V281L and P105LCP453S). The patients
with 3b-HSD deﬁciency and 46,XX were excluded from
further analysis of the data but are separately described
at the end of this section. Thus, 30 patients were
included in the statistical analysis.
Glucocorticoids were taken by 93% (28/30) of the
patients. One recently diagnosed 29-year-old man
(I172N) took no medication and another with the NC
phenotype (V281L) only used prednisolone when
acutely ill. The most frequently used preparations
were prednisolone (62%, 18/29) and hydrocortisone
(17%, 5/29). The mean dose expressed in glucocorticoid
equivalents was 32.7G12.4 mg using the conversion
previously described (19). Urine pregnanetriol and
blood 17OHP diurnal curves were similar for the
different genotypes and age groups (15).
Most patients (87%, 26/30) received ﬂudrocortisone,
which was also received by most of the SV patients
(82%, 9/11) and one of the NC patients. The SVand NC
patients used ﬂudrocortisone to minimize the gluco-
corticoid dose. None of the CAH males had experienced
prostate problems. In the control group, a 67-year-old
man had antiandrogen therapy after prostatectomy for
cancer and was excluded in all calculations concerning
testicular function, a 58-year-old man was operated on
for benign prostatic hyperplasia, and a 45-year-old man
had recurrent prostatitis.
Fertility, fecundity, and sexuality
On comparing the number of biological children of CAH
patients with age-matched national data, the fertility
was low (in all patients, 0.9G1.3 vs 1.8G0.5; !30
years, 0.1G0.3 vs 1.3G0.4; R30 years, 1.2G1.4 vs
2.0G0.3; children/father, P!0.001 for all compari-
sons). Inpatients with classic 21-hydroxylase deﬁciency,
the corresponding frequency was 0.9G1.3. The
reduction of fertility was similar in the three genotype
groups (null, I2splice, and I172N) compared with age-
matched national data (P!0.001). One NC man had
three while the other had no children. However,
compared with our investigated controls, fertility and
the age at the time of birth of the ﬁrst child (not shown)
were similar although more patients than controls
had experienced fecundity problems (Table 1). Three
patients had attempted to father but never succeeded,
compared with one control, but one of them fathered
a child 1 year after the investigation. The rate of
marriage/cohabitation was similar in the entire patient
group compared with controls. A propensity to
increased frequency of marriage/cohabitation in older
compared with younger subjects was only found in
controls. A similar percentage of patients and controls
had no partner (Table 1). One control had two adopted
children.
The age at sexual debut and frequency of intercourse
were similar between the groups (not shown), but the
lifetime number of partners was lower in the total group
of patients and in older patients compared with
controls. One control declared that he was homosexual
compared with none in the patient group. No
bisexuality was reported. As shown in Table 2, there
was no difference between the genotype groups
regarding fertility, fecundity, and sexuality. However,
compared with controls, the null group patients have
had fewer partners, fewer I2splice patients were
married/cohabitants, and fecundity problems were
more common in the I172N group patients.
Biochemical tests
Inhibin B was lower and FSH higher in all groups of
CAH males compared with controls (Tables 1 and 2).
The values were negatively associated in the entire
patient cohort (rZK0.514, P!0.001). Three patients
had subnormal inhibin B and four had elevated FSH
concentrations. No differences in LH levels were found.
No subject displayed subnormal FSH or LH.
As expected, both older patients and controls had
lower bioactive testosterone than the younger ones. An
overall tendency to lower bioactive testosterone and
higher E2 in patients than in controls resulted in a
signiﬁcant decrease of the testosterone/E2 ratio in all
and older patients, with the latter also having a lower
ratio than their younger counterparts (Table 1). SHBG
was similar in all groups (not shown). Total PSA and
free PSA concentrations were similar in all comparisons
(not shown).
Testicular examination
At manual palpation performed in 70% (21/30) of
patients and controls, smaller testicular volumes were
found in patients compared with controls (Table 1).
Patients with the null mutation had smaller testicles
than those with other genotypes or controls.
A unilateral tumor was palpated in one patient and
multiple bilateral tumors in another (Table 1). However,
with the aid of ultrasound (completed in 70% (21/30)),
86% (18/21) were shown to have TARTs, which were
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a TART from one of the patients is shown in Fig. 1.
No signiﬁcant difference was found in TART frequency
and number, total TART volume, or functional
testicular volume between genotypes (Table 3). Two
patients with genotypes associated with very mild
disease (V281L and P105LCP453S) had small TARTs
(0.31–0.38 cm
3).
Patients with the largest TARTs (nZ8, volume
O1c m
3) had similar age and fat mass but higher lean
mass (19.5G2.4 vs 16.6 kg/m
2, PZ0.025) and shorter
height (162G8 vs 173G6 cm, PZ0.011) than those
with no or very small TARTs (nZ7, volume !0.2 cm
3).
Poor treatment control, arbitrarily deﬁned as urinary
pregnanetriol R100 mmol/24 h and/or a 24-h median
17OHP value R100 nmol/l, was found in three of
the eight patients with larger TARTs but in none of
those with no or very small TARTs.
Two patients had undergone previous testicular
surgery for suspected malignancy. In both cases, the
histopathology was interpreted as benign Leydig cell
tumors. One 41-year-old SW patient (I2splice) had
a testicular tumor extirpated at 12 years of age.
He now had one small tumor in each testicle (volume
0.11 cm
3), normal semen, and two biological children.
In a 34-year-old SW patient (I2splice) with two
biological children, a tumor was removed before
conception. He now showed multiple bilateral tumors.
One 23-year-old SV patient (I2splice) with TARTs had
been operated on for testicular retention at age 17.
No testicular intervention was reported in any of the
controls.
Semen analysis
Semen for analysis was obtained from 14 of the 30
CAH males. Fecundity problems tended to be more
common in those who delivered a semen sample than
in those who declined (5/14 vs 1/16, PZ0.072). The
mean ages were similar (37.7G12.7 vs 35.6G11.9
years).
Considering all WHO criteria, six of the 14 semen
samples were pathological. The results were similar
in younger and older patients (not shown). A lower
sperm count, concentration, and motility in I172N
compared with the I2splice group did not reach
statistical signiﬁcance in this limited material
(Table 3). Only one patient in the null group had an
analyzed sample and it was pathological. One 39-year-
old patient with SV (I172N) had severe teratozoos-
permia with impaired motility and a previously
performed intracytoplasmic sperm injection (ICSI)
resulting in one child.
We found that inhibin B levels, regarded as a
marker of spermatogenesis, were negatively correlated
to body mass index (BMI; rZK0.509, PZ0.004) in
the controls and demonstrated a similar trend in
the patients (rZK0.317, PZ0.087). Hence, body
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risk were compared in males with pathological and
normal semen. Males with pathological semen had a
higher truncal and total fat mass, total fat/lean mass
ratio, and heart rate, in spite of similar 17OHP levels
and corticosteroid doses (Table 4).
Associations among TARTs, sperm number and
quality, and the gonadotropin–gonadal
steroid axis
As shown in Fig. 2, total functional testicular volume
was positively correlated with inhibin B levels and
sperm concentration. There was also a trend to a
positive association with sperm volume (rZ0.60,
PZ0.059) and a signiﬁcant positive correlation with
the testosterone/E2 ratio (rZ0.50, PZ0.029). We also
found the expected positive associations between
inhibin B total functional testicular volume and the
sperm count (rZ0.64, PZ0.014) and concentration
(Fig. 2) and with normal morphology (rZ0.48,
PZ0.061). FSH showed a negative correlation with
sperm count (rZK0.53, PZ0.047) and concentration
(rZK0.70, PZ0.004). The total TART volume tended
to be negatively associated with height (rZK0.44,
PZ0.056) and was positively correlated with LH
(rZ0.41, PZ0.046). There was no correlation with
other hormones of the gonadotropin–testicular axis. No
correlation was demonstrated between total TART
volume or functional testicular volume and age,
glucocorticoid dose, plasma renin, and ACTH concen-
trations (not shown).
Male with 3b-HSD type II deﬁciency
The patient with 3b-HSD deﬁciency was 21 years old,
had male external genitalia with a micropenis, lived
alone, and had no children. On testicular palpation,
bilateral multiple tumors were found and ultrasound
showed a very small total functional volume (1.9 cm
3)
due to large bilateral TARTs measuring 25.6 cm
3.
A tumor measuring 2.4!1.8!1.5 cm, with a weight
of 3.2 g, was extirpated. He had no sperm in the semen
sample, but a testicular biopsy was able to retrieve
w100 severely abnormal sperms, which were saved for
future ICSI. He had poor control with high DHEAS, and
his FSH and LH were also high while inhibin B was low.
Male with karyotype 46,XX and
21-hydroxylase deﬁciency
The 46,XX CAH male was 61 years old and had a 4 cm
phallos. He was diagnosed at age 7 when ovaries and a
uterus had been found and was subsequently extir-
pated, following which he underwent glucocorticoid
and testosterone replacement. He was married and had
adopted two children.
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This study conﬁrms that fertility is reduced in males
with classic CAH. They also had fecundity problems
more often than control men. TARTs were present in the
majority of patients; hormonal evaluation demon-
strated disturbed testicular function involving both
Sertoli and Leydig cells, and in about half of the patients
who had semen analysis performed, abnormal semen
was found. Psychosocial and sexual issues were also
investigated, but their impact on overall fertility rate
appears modest.
The fertility rate was reduced by one half compared
with national data and was impaired in all genotype
groups associated with classic CAH. No obvious reason
was found in the patients’ social or sexual life. Although
the patients were less experienced than controls in
terms of number of sexual partners through life, the age
at sexual debut, the rate of marriage/cohabitation, and
the present coitus frequency were similar in patients
and controls. More fecundity problems were reported,
however, by the men in the I172N group. This may be
due to metabolic factors (see below).
One reason for the decreased birth rate in females
with CAH is increased homo- and bisexuality, with
fewer individuals living in heterosexual relationships
(13, 20). Among the male patients, none reported
homo- or bisexuality. This is in keeping with the only
previous report on sexual orientation studying nine
CAH males (21).
Most likely, the predominant reason for reduced
fertility is the frequent occurrence of TARTs, which
were found in 86% of the examined patients, similar to
the highest frequency reported previously (6). Others
report prevalences of 0–67%, which probably reﬂects
differences in the mode of detection and age of the
patients (1, 2, 4, 5, 7, 9, 10, 11, 12). TARTs have been
demonstrated in children at a frequency of slightly
above 20% and found even in children 6 years of age
(22, 23). Autopsy data have indicated TARTs in CAH
boys of a few weeks of age (24).
We found TARTs in all genotype groups. Even both of
our NC patients who had normal ACTH levels had small
TARTs, which has previously been reported only with
clearly elevated ACTH or angiotensin II (AII) (3).I n
contrast, a recent study found no case of TART in the
I172N or the NC genotypes (9). Others have, however,
also reported TARTs in I172N patients (4, 5, 22), and in
patients with SV (11). Another recent report found
Figure 1 Illustration of the steps in the 3D inversion rendering
process of right testicle of a 30-year-old male with CAH (genotype
null/null) with two children. Acquisition in the three orthogonal
planes and the rendered volume in the bottom right box. By
eliminating the surrounding non-pertinent structures with the
electronic scalpel, the structures of interest were left as the ﬁnal
inverted and rendered volume. In this case, it could be seen that the
tumor was calciﬁed and had a cystic structure (right bottom corner,
the tumor marked with an arrow). In the left upper box, the tumor is
marked with arrows (the size of the tumor was measured to be:
2.6!1.1!0.9 cm, corresponding to a volume of 1.4 cm
3). Full
colour version of this ﬁgure available via http://dx.doi.org/10.1530/
EJE-11-0828.
Table 3 Testicular ultrasound exams and semen samples from adult patients with CAH and the three most common CYP21A2 genotypes
(meanGS.D. or median and range).
Patients Null I2splice I172N
P value
genotypes
Ultrasound nZ21 nZ4 nZ10 nZ4
Total volume (cm
3) 22.7G7.5 18.7G9.0 24.6G6.0 24.4G11.6 NS
TART present 18/21 4/4 8/10 4/4 NS
TART (n) 2.0 (0–8) 2.0 (1–5) 2 (0–8) 1.5 (1–2) NS
Total TART (cm
3) 0.5 (0–8.7) 2.9 (1.9–4.6) 0.2 (0–8.7) 0.5 (0.2–4.3) 0.083
Total functional (cm
3) 20.4 (7.1–36.7) 15.6G8.1 24.4G5.7 23.0G9.8 NS
Semen sample nZ14 nZ1 nZ6 nZ6
Volume (ml) 2.3G0.6 1.5 2.3G0.5 2.2G0.6 NS
a
Sperm count (!10
6) 151G112 105 220G146 88G19 0.053
a
Sperm conc. (!10
6/ml) 70G54 70 99G71 44G18 0.094
a
Motile sperm (%) 53G21 30 64G11 42G23 0.060
a
Normal morphology (%) 3.2G2.8 1.0 4.5G3.4 2.2G1.9 NS
a
Pathological semen 6/14 1/1 3/7 2/5 NS
NS, non-signiﬁcant; TART, testicular adrenal rest tumor.
aOnly one male null/null patient provided a semen sample, thus comparisons were only performed between I2splice and I172N.
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mean age of our patients compared with many of the
previous studies may explain some of the differences.
Only 10% of TARTs were found by clinical examination
in our cohort and it has been stated that usually only
TARTs O2 cm are detectable by palpation due to being
buried within the testis (3). Consequently, all CAH
males, including those with the milder pheno- and
genotypes, should be examined periodically by testicular
ultrasound and not only the classic ones.
It is alarming that two (6.7%) of the CAH males had
undergone testicular surgery for suspected malignancy
with histology showing TARTs. Almost the same fre-
quency of unnecessary testicular surgery for presumed
malignancyhasrecentlybeenreportedfromalargecohort
of CAH males (6.2%, 4/65) (10). Thus, an increased
awareness and understandingof TARTs is needed.
There were associations in favor of a negative impact
of TARTs on fertility. Total functional testicular volume
was positively correlated with sperm parameters and
inhibin B. Semen quality has recently been reported to
be very poor in CAH males, with 100% being patho-
logical if all the WHO criteria were considered (4).
Our patients appeared less affected; using the same
criteria, 43% of our CAH males had abnormal semen.
The results of several studies point to an increased
likelihood of abnormal semen parameters among
overweight men and obesity is associated with a higher
incidence of male factor infertility (25). In large cohorts,
decreased sperm quality was found already in over-
weight (BMI 25–30 kg/m
2) compared with normal
weight men (26). One of the proposed mechanisms is
that increased estrogens due to aromatization of
androgens in the adipose tissue can hamper fertility
(25). Elevated fat mass is often found in CAH (27, 28),
and our CAH males with abnormal semen demon-
strated increased total and abdominal body fat, and fat
to lean mass ratio compared with CAH males with
normal semen. Overall, our patients had a lower
testosterone/E2 ratio although the difference in these
parameters between individuals with normal and
pathological semen did not reach signiﬁcance in the
Table 4 Patient characteristics and differences found in body
composition, heart rate, blood pressure, and biochemical tests in
adult CAH male patients with pathological and normal semen
(meanGS.D. or median and range).
Pathological
(nZ6)
Normal
(nZ8) P value
Age (years) 40.3G15.1 35.8G11.2 NS
Phenotype 4SW/2SV 4SW/2SV NS
HCeq/m
2 (mg/m
2) 18.9G8.4 15.4G2.2 NS
BMI (kg/m
2) 29.4G6.3 25.3G4.1 NS
Total fat mass (%) 32.0G8.2 24.3G5.7 0.049
Truncal fat mass (%) 35.2G9.7 25.9G7.0 0.048
Total fat/lean mass 0.5G0.2 0.3G0.1 0.032
24-h BP (mmHg) 134G6/79G5 123G11/74G5 0.062/0.099
24-h heart rate 81G57 3 G5 0.012
Fecundity problems
a 5/6 0/8 0.003
FSH O10 (U/l) 2/6 0/8 NS
Inhibin B (ng/l) 157G57 167G102 NS
Testosterone (nmol) 12.5G3.2 17.8G6.2 0.064
Testos/E2 (nmol/pmol) 0.17G0.04 0.19G0.07 NS
S-TG (mmol/l) 1.5G1.0 0.9G0.3 0.095
NS, non-signiﬁcant; HCeq, hydrocortisone equivalents; TG, triglyceride; BP,
blood pressure; testos/E2, testosterone/estradiol ratio.
aFertility problems deﬁned as attempting to father a child for O1 year.
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Figure 2 Correlation between inhibin B (upper panel), total
functional testicular volume (lower panel) and sperm concentration,
and total functional testicular volume and inhibin (middle panel) in
adult males with CAH due to 21-hydroxylase deﬁciency.
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tended to have a lower sperm quality compared with
the I2splice patients, perhaps reﬂecting their previously
reported negative cardiometabolic proﬁle (15). Meta-
bolic risk has been associated with decreased fertility
and impaired sperm quality (29). None of the patients
showed suppression of gonadotropins, which could be
expected with extreme over- or undertreatment with
glucocorticoids (3, 4).
Apart from conventional infertility treatment, there
are few speciﬁc measures to offer CAH men with fertility
problems. Weight loss may improve fertility in obese
men (25) and normal weight should be aimed at.
TARTs possess receptors for both ACTH and AII, and
it has been hypothesized that high levels due to
undertreatment with corticosteroids may enhance
their growth (30). We found no correlation between
TART volume and current ACTH or renin levels.
However, subjects with large TARTs were shorter and
had higher lean mass compared with those with no or
very small TARTs. Almost 40% of patients with large
TARTs had very high levels of urinary pregnanetriol and
blood17OHP,therebyindicatingbothpoorcontrolduring
adolescence and later. Increased glucocorticoid doses
can reduce the size of the TARTs in the early stages, but
continued growth is also seen when ACTH levels are
suppressed. It remains unknown whether this is due to
persistent stimulation via AII receptors or by other
mechanisms as the effect of increased mineralocorticoid
doses has not been systematically studied. Unfortunately,
higher doses of glucocorticoids and mineralocorticoids
will most certainly increase the frequency and severity
of side effects (10, 15, 28, 31, 32). In later stages,
testicular surgery may sometimes be helpful, but in the
end, when damage is irreversible, treatment options are
verylimited(3).Preservationofspermcouldbeconsidered
before the TARTs have grown too much.
Fertility in 3b-HSD deﬁciency has not been studied
(33), but our patient was infertile with no sperm in his
semen sample. Biopsy revealed a few severely affected
sperms; ultrasound and surgery revealed virtually no
functional testicular volume.
The major limitation of this study is its size despite
being larger and including older CAH males than many
other studies. Negative ﬁndings must therefore be
interpreted with caution. Moreover, our controls had
lower fertility than expected. Many of our patients did
not collect a semen sample and a comparison with those
who did indicated a selection bias as fecundity issues
tended to be more prevalent in the latter group. Hence,
those with problems appeared more motivated to
produce a sample.
In conclusion, impaired fertility and fecundity were
detected in adult men with CAH. Sexual and social
issues appeared to have limited impact on fertility. The
most obvious cause is the presence of TARTs, but other
causes may contribute. Decreased semen quality was
prevalent and those with pathological semen also had
higher fat mass. The male with 3b-HSD deﬁciency was
infertile. In spite of these ﬁndings, most males with CAH
due to 21-hydroxylase deﬁciency who wish to be fathers
seem to succeed eventually.
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